Bill · S. 2770· Senate(119-S-2770)
Share the Savings with Seniors Act
- Introduced
- 9/11/2025
- Last activity
- 9/11/2025 — Read twice and referred to the Committee on Finance.
- Sponsored by
- John Cornyn
- Cosponsors
- - 1 - 2
- Introduced
- In Committee
What this bill would do
The "Share the Savings with Seniors Act" aims to amend the Social Security Act regarding Medicare Part D. It establishes new cost-sharing rules specifically for "chronic care drugs" starting January 1, 2027. For these drugs, cost-sharing below the annual deductible cannot exceed the net price. For costs above the deductible, coinsurance must be based on a percentage of the net price, unless a specific copayment exception applies. The bill defines chronic care drugs through various USP categories like blood glucose regulators and anticoagulants.
Yes· 3 of 6
Would people over 65 be better off under this?+6
The bill provides financial relief to seniors by capping cost-sharing for essential chronic care drugs under Medicare Part D.
Would retired people be better off under this?+6
The bill lowers the financial burden of chronic medication costs for retirees enrolled in Medicare Part D plans.
Does this lower the price of prescription medicines?+6
The bill limits cost-sharing for specific chronic care drugs like blood glucose regulators and anticoagulants to a percentage of the net price.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Reduced costs before reaching deductibles: For plan years beginning on or after January 1, 2027, cost-sharing for a chronic care drug will not exceed the net price of that drug for costs below the annual deductible (Section 2(a)(1)(A)(i)).
-
Standardized coinsurance for chronic care drugs: For costs above the annual deductible but below the out-of-pocket threshold, coinsurance for these drugs will be based on a percentage of the net price (Section 2(a)(1)(A)(ii)).
-
Protections for low-income individuals: For the year 2027 and subsequent years, the copayment amount for a chronic drug cannot exceed the applicable cost-sharing for that drug under the individual's specific prescription drug or MA-PD plan (Section 2(b)).
Potential Negative Impacts for People
- Exceptions to the new pricing rules: The requirement to base coinsurance on a percentage of the drug's net price may not apply if the cost-sharing is based on a copayment not tied to a drug price, such as a negotiated price, list price, wholesale acquisition cost, or a drug benchmark price (Section 2(a)(1)(A)(B)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+6Good For Seniors+6Good For Low Income Households+5
- Healthcare
- Reduces Prescription Drug Costs+6Increases Medicare Funding+2
- Social Issues And Justice
- Improves Social Security+3
- 9/11/2025
- Read twice and referred to the Committee on Finance.
- 3 Cosponsors added.
- Introduced in Senate
Jacky RosenDemocrat · Nevada
Thomas TillisRepublican · North Carolina
Peter WelchDemocrat · Vermont